The blockbuster weight loss drug sold as Ozempic and Wegovy [has, on 21 March, gone] generic in countries that are home to 40 percent of the world’s population, significantly lowering the price of a costly medicine that had been largely unaffordable to nearly all but the wealthiest people. On Saturday, Novo Nordisk, the company that until now has had a monopoly on selling the drug, will lose patent protection in several of the world’s most populous countries. The first generic versions are expected to arrive in India as soon as this weekend. In the coming months, the generics are also expected to become available in China, Canada, Brazil, Turkey and South Africa.
Exactly. And these drugs were originally diabetes medications. And they don’t cure diabetes.
the only reason they were diabetes meds was because obesity and high carb intake is the cause of most type 2 diabetes.
All these drugs do is trick the brain into thinking you just over ate.
Not directly.
But borderline people who lose a lot of weight can sometimes get into the range of non-insulin-dependent life.
that’s type 2 and I’m early stages.
i hope that my example made it clear I didn’t mean those cases.
Ozempic doesn’t do much for type 1. It was never approved for type 1.